As per IMS, the global market for Pharmaceuticals is expected to grow nearly USD 300 bn over the next five years, reaching USD 1.1 trillion in 2014. The 5-6% compound annual growth rate (CAGR) during this period reflects the impact of leading products losing patent protection in developed market, as well as strong overall growth in the world’s emerging countries. Global Pharmaceutical sales growth of 4-6% is expected in 2010. In 2009, the market grew 7% to USD 837 bn, compared with a 4.8% growth rate in 2008.

Geographic balance of the Pharmaceutical market continues to shift towards emerging countries. Emerging markets are expected to grow at a 14-17% pace through 2014, while major developed markets will grow 3-6%. As a result, the aggregate growth through 2014 from emerging market will be similar to the growth experienced in developed markets – about USD 120-140 bn. This compares to aggregate growth over the past five years of USD 69 bn in emerging markets and single largest markets and 126 bn in emerging market, with 3-6 % growth expected annually in the next five years and reaching USD 360-390 bn in 2014,up from USD 300 bn in 2009.

We will continue to focus on our strength that is our existing business in CIS countries but aiming to make our presence felt in countries under future expansion like South East Asians and Eastern European countries. In fact we have already initiated our Indian operation.